Home    Back

Amniotic epithelial cells    (DrugBank: Amniotic Epithelial Cells)

1 disease
IDDisease name (Link within this page)Number of trials
26HTLV-1-associated myelopathy1

26. HTLV-1-associated myelopathy    [ 26 clinical trials,   46 drugs,   (DrugBank: 27 drugs),   37 drug target genes,   123 drug target pathways]
Searched query = "HTLV-1-associated myelopathy", "Tropical spastic paraparesis", "HTLV-1", "HTLV-I-associated myelopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 26 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02961712
(ClinicalTrials.gov)		July 20163/11/2016Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)Immunotherapy of Natural Killer in HTLV-1 Associated MyelopathyHAMBiological: NK cells;Biological: amniotic epithelial cellsThe Second Affiliated Hospital of Fujian Medical UniversityShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruiting18 Years75 YearsAll15Phase 1China